PestleMedicine Explained

Empagliflozin

Empagliflozin is an SGLT2 inhibitor medicine. It is used to treat type 2 diabetes in adults and children aged 10 years and older when diet and exercise alone are not enough, and to treat heart failure and chronic kidney disease in adults.

Active ingredient: empagliflozin

Official leaflet

Key facts

  1. It lowers blood sugar by making your kidneys remove sugar in your urine, so your urine will test positive for sugar.
  2. Keep following the diet and exercise plan your doctor has given you.
  3. Contact a doctor or the nearest hospital straight away if you have signs of ketoacidosis, such as rapid weight loss, feeling or being sick, stomach pain, excessive thirst, fast and deep breathing, confusion or a sweet smell on your breath.
  4. Your kidneys should be checked before you start and while you take this medicine.
  5. Do not stop taking it without speaking to your doctor, unless you suspect ketoacidosis.

Who should not take empagliflozin

The leaflet says not to take it if any of these apply to you.

  • If you are allergic to empagliflozin or any of the other ingredients of this medicine

Check with a doctor or pharmacist first

Tell them before you take it if any of these apply to you.

  • Ketoacidosis symptoms: contact a doctor or hospital straight away and stop taking the medicine until advised
  • Risk of ketoacidosis may be higher with prolonged fasting, excessive alcohol, dehydration, sudden reductions in insulin dose, or a higher need for insulin due to major surgery or serious illness
  • Type 1 diabetes: you should not take empagliflozin
  • Serious kidney problems: your doctor may limit your dose to 10 mg once a day or give a different medicine
  • Serious liver problems: your doctor may give a different medicine
  • Risk of dehydration, for example being sick, having diarrhoea or fever, not being able to eat or drink, taking diuretics or blood pressure lowering medicines, or being 75 or older
Show 6 moreShow fewer
  • Serious infection of the kidney or urinary tract with fever: your doctor may ask you to stop until you recover
  • Pain, tenderness, redness or swelling of the genitals or the area between the genitals and the anus with fever or feeling unwell: talk to your doctor immediately (possible Fournier's gangrene)
  • Check your feet regularly and follow foot care advice
  • Your urine will test positive for sugar while taking this medicine
  • Not recommended under 18 years for heart failure or chronic kidney disease; no data for children under 10 years with type 2 diabetes
  • Contains lactose: speak to your doctor if you have been told you have an intolerance to some sugars

How to take empagliflozin

  • The recommended dose is one 10 mg tablet once a day; for type 2 diabetes your doctor may increase it to 25 mg once a day if needed.
  • Your doctor may limit your dose to 10 mg once a day if you have a kidney problem.
  • Swallow the tablet whole with water, with or without food, at any time of day, but try to take it at the same time each day.
  • If you miss a dose and it is 12 hours or more until the next one, take it when you remember; if it is less than 12 hours, skip it. Never take a double dose.
  • Do not change your dose or stop taking it unless your doctor tells you to.

Side effects

Get medical help straight away

The leaflet says to get help urgently, or to stop the medicine and speak to a doctor, if you notice any of these. In an emergency call 999.

  • Severe allergic reaction, such as swelling of the face, lips, mouth, tongue or throat that may lead to difficulty breathing or swallowing (uncommon)
  • Ketoacidosis (uncommon)
  • Necrotising fasciitis of the perineum or Fournier's gangrene (rare)

How common each side effect is

Grouped the way the leaflet groups them. Most people get none, or only a few. Each figure is the most that are affected, so "up to 1 in 10" can mean far fewer.

Very common

More than 1 in 10 people

  • Low blood sugar (hypoglycaemia)
  • Dehydration

Common

Up to 1 in 10 people

  • Urinary tract infection
  • Genital yeast infection (thrush)
  • Passing more urine than usual or needing to pass urine more often
  • Itching
  • Rash or red skin
  • Thirst
  • Increase in blood fat (cholesterol) levels in blood tests
  • Constipation

Uncommon

Up to 1 in 100 people

  • Severe allergic reaction
  • Ketoacidosis
  • Hives
  • Straining or pain when emptying the bladder
  • Decrease in kidney function (creatinine or urea) in blood tests
  • Increases in the amount of red blood cells (haematocrit) in blood tests

Rare

Up to 1 in 1,000 people

  • Necrotising fasciitis of the perineum or Fournier's gangrene

Very rare

Up to 1 in 10,000 people

  • Inflammation of the kidneys (tubulointerstitial nephritis)

If you get a side effect, you can report it to the regulator through the Yellow Card scheme.

Pregnancy and breastfeeding

Do not use empagliflozin if you are pregnant, as it is unknown whether it is harmful to the unborn child. Do not use it if you are breast-feeding, as it is not known whether it passes into breast milk. Ask your doctor or pharmacist for advice if you are pregnant, think you may be, or are planning a baby.

Taking it with other medicines

The leaflet says to tell your doctor or pharmacist if you take any of these. This list is not checked against the medicines you take.

  • Medicines that increase urine production (diuretics)
  • Other medicines that lower blood sugar, such as insulin or a sulphonylurea medicine
  • Lithium

Where this comes from

Everything on this page is taken from one official document: the patient information leaflet that the UK medicines regulator (MHRA) approved for this product. Pestle reorganises it and puts it in plainer words. It adds nothing from anywhere else and does not rate medicines.

Product
Empagliflozin 25 mg Film-Coated Tablets
Product licence
PL 16363/0907
Leaflet dated
Checked against the leaflet
Automated check
18 of 18 side effects matched to the wording of the leaflet

Other makers of empagliflozin publish their own leaflets, which can differ slightly. Always read the leaflet that came with your medicine.

Read the official leaflet Original on the MHRA site How we make these pages

The same facts for software and AI agents: JSON · Markdown.